Executive Gov
  • Home
  • Acquisition & Procurement
  • Agencies
    • DoD
    • Intelligence
    • DHS
    • Civilian
    • Space
  • Cybersecurity
  • Technology
  • Awards
  • News
  • About
  • Wash100
  • Contact Us
    • Advertising
    • Submit your news
No Result
View All Result
Executive Gov
  • Home
  • Acquisition & Procurement
  • Agencies
    • DoD
    • Intelligence
    • DHS
    • Civilian
    • Space
  • Cybersecurity
  • Technology
  • Awards
  • News
  • About
  • Wash100
  • Contact Us
    • Advertising
    • Submit your news
No Result
View All Result
Executive Gov
No Result
View All Result
Home Government Technology

Oracle Utilizes Therapeutic Learning System to Record COVID-19 Drug Effectiveness

by Sarah Sybert
December 6, 2022
in Government Technology, News
Oracle Utilizes Therapeutic Learning System to Record COVID-19 Drug Effectiveness

Oracle Utilizes Therapeutic Learning System to Record COVID-19 Drug Effectiveness

Table of Contents

  • You might also like
  • INL to Help Lead Nuclear Energy Work Under INEC Tech Hub
  • Marines Evaluate New UAS Capabilities to Strengthen Regimental Operations
  • Chris Fall Steps Down as CAISI Director, NIST Chief Raman to Serve as Acting Head

You might also like

INL to Help Lead Nuclear Energy Work Under INEC Tech Hub

Marines Evaluate New UAS Capabilities to Strengthen Regimental Operations

Chris Fall Steps Down as CAISI Director, NIST Chief Raman to Serve as Acting Head

Oracle has utilized its technology platform in the ongoing fight against COVID-19 to develop and deploy a series of cloud applications that will gather the data necessary to determine what drugs are effective in treating or preventing the virus, the company announced on Thursday.

The company has used a clinical trials system, which has examined many drugs including the cancer drug Keytruda, that have been approved by regulators worldwide after Oracle Clinical Trial Systems.

The system has collected data to prove drugs were both safe and effective. The Oracle Cloud has begun testing the safety and effectiveness of dozens of different COVID-19 drugs and vaccines. The trials will be completed in many countries and hundreds of institutional sites.

Oracle’s newest cloud system, Clinical One, will enable institutions to start-up a clinical trial in as few as two weeks. The company has also integrated a therapeutic learning system in addition to gathering data from COVID-19 clinical trials.

The company has built and donated to the US government a COVID-19 Therapeutic Learning System that has allowed physicians and patients to record the effectiveness of COVID-19 drug therapies, such as Hydroxychloroquine, Remdesivir and Kaletra.

The drugs have been safely used to treat other diseases but are not yet definitively proven to be effective against COVID-19. Physicians are now routinely prescribing these drugs to treat COVID-19 patients.

Oracle’s Therapeutic Learning System will enable the physician to record the patient’s daily progress. The solution will quickly discover which of the new drugs are most effective against COVID-19, optimal dosages and how early in the disease progression the drugs need to be administered.

The Therapeutic Learning System was the result of a partnership with the National Institute of Health, the Food and Drug Administration, the Center for Disease Control and Prevention, Centers for Medicare & Medicaid Services and the Department of Health and Human Services.

About Oracle  

The Oracle Cloud offers a complete suite of integrated applications for Sales, Service, Marketing, Human Resources, Finance, Supply Chain and Manufacturing, plus Highly Automated and Secure Generation 2 Infrastructure featuring the Oracle Autonomous Database.

Stay connected via Google News
Follow us for the latest travel updates and guides.
Add as preferred source on Google
Share5Tweet19

Recommended For You

INL to Help Lead Nuclear Energy Work Under INEC Tech Hub

by Jane Edwards
July 21, 2026
Idaho National Laboratory logo. INL will help lead nuclear energy tech work under the INEC Tech Hub.

INL has secured a leading role in the INEC Tech HubThe initiative pairs a $31 million federal grant with $9 million in matching fundsThe Tech Hub is expected...

Read moreDetails

Marines Evaluate New UAS Capabilities to Strengthen Regimental Operations

by Marshall Quinn
July 21, 2026
U.S. Marine Corps. 2nd Marines test JUMP 20-X with Switchblade 300, marking first Group 3 UAS regimental trial.

2nd Marine Regiment has tested the JUMP 20-X drone with a Switchblade 300 munition.The unit engaged a target 25 kilometers away during Service Level Training Exercise 4-26.The test...

Read moreDetails

Chris Fall Steps Down as CAISI Director, NIST Chief Raman to Serve as Acting Head

by Jamie Bennet
July 21, 2026
Chris Fall. The CAISI director has resigned after three months in office.

Chris Fall has vacated the role of director of the Center for AI Standards and Innovation after three months in officeHe will be temporarily replaced by Arvind Raman,...

Read moreDetails

Executive Order Seeks to Advance Domestic Critical Material Sourcing, Limit Waivers

by Jane Edwards
July 21, 2026
White House. President Trump signed an executive order directing DOW to restrict waivers for critical materials.

The order limits waivers for critical materials from covered countriesThe order requires contractors to map critical supply chains for national security acquisitionsExplore defense modernization priorities at the Potomac...

Read moreDetails

NASA, GE Aerospace Complete Flight Demo of Megawatt-Class Hybrid-Electric Engine

by Jamie Bennet
July 21, 2026
GE Aerospace. The company, along with NASA, completed a test flying a Saab 340B aircraft with a hybrid-electric engine.

NASA and GE Aerospace have completed a test flight of a Saab 340B aircraft mounted with a megawatt-class hybrid-electric engineThe vehicle is the first hybrid electric-powered aircraft to...

Read moreDetails
Sign Up For Our Newsletter
Subscribe to our mailing list to receives daily updates direct to your inbox!
Invalid email address
Your privacy is guranteed.
Thanks for subscribing!

Sponsors

About ExecutiveGov

ExecutiveGov, published by Executive Mosaic, is a site dedicated to the news and headlines in the federal government. ExecutiveGov serves as a news source for the hot topics and issues facing federal government departments and agencies such as Gov 2.0, cybersecurity policy, health IT, green IT and national security. We also aim to spotlight various federal government employees and interview key government executives whose impact resonates beyond their agency.

CATEGORIES

  • Acquisition & Procurement
  • Announcements
  • Articles
  • Artificial Intelligence
  • Awards
  • Big Data & Analytics News
  • C4ISR
  • Civilian
  • Cloud
  • Contract Awards
  • Cybersecurity
  • Defense And Intelligence
  • Defense Security Cooperation
  • DHS
  • Digital Assets
  • Digital Modernization
  • DoD
  • Events
  • Executive Moves
  • Executive Spotlights
  • Federal Civilian
  • Financial Reports
  • Foreign Military Sales
  • General News
  • GovCon Expert
  • Government Cloud
  • Government Technology
  • GSA
  • Healthcare IT
  • Industry News
  • Intelligence
  • Legislation
  • M&A Activity
  • National Security
  • News
  • Policy Updates
  • Press Releases
  • Profiles
  • Space
  • Videos
  • Wash100
Sign Up For Our Newsletter
Subscribe to our mailing list to receives daily updates direct to your inbox!
Invalid email address
Your privacy is guranteed.
Thanks for subscribing!

Copyright 2026 Executive Mosaic. All Rights Reserved. Site Archive

No Result
View All Result
  • Home
  • Acquisition & Procurement
  • Agencies
    • DoD
    • Intelligence
    • DHS
    • Civilian
    • Space
  • Cybersecurity
  • Technology
  • Awards
  • News
  • About
  • Wash100
  • Contact Us
    • Advertising
    • Submit your news

Copyright 2026 Executive Mosaic. All Rights Reserved. Site Archive

Get your free GovCon news!

Get your latest GovCon news and insights. Become a VIP and subscribe to the GovConWire Daily News.

Invalid email address
We promise not to spam you. You can unsubscribe at any time.
Thanks for subscribing!